News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
224
Sources here
19
Companies here
8
Search results Stored financial headlines

Active search

224 matching headlines

Ticker or company: FISHMain company stories
Clear
Latest

Simply Wall Street Earnings

Thermo Fisher (TMO) Stock May Be 8% Below Fair Value On Microbiology Sale

Thermo Fisher Scientific (TMO) stock has gained 20.7% over the last year and appears modestly undervalued by about 7.6% according to a Discounted Cash Flow (DCF) model, suggesting it's close to its intrinsic value. While a recent sale of its microbiology business and focus on proteomics and precision medicine support future cash generation, the P/E ratio indicates it …

Simplify Asset Management Inc. Buys 5,670 Shares of Thermo Fisher Scientific Inc. $TMO

Simplify Asset Management Inc. increased its stake in Thermo Fisher Scientific Inc. (TMO) by 32.6% in the second quarter, purchasing 5,670 additional shares. This brings their total holding to 23,079 shares, valued at approximately $11.6 million. Institutional investors collectively own 89.23% of TMO, with …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

HM Payson & Co. Sells 20,885 Shares of Thermo Fisher Scientific Inc. $TMO

HM Payson & Co. reduced its stake in Thermo Fisher Scientific Inc. by 11.3%, selling 20,885 shares but still holding 163,790 shares valued at $82.1 million. Despite insider selling of over $30.6 million in the last 90 days, Thermo Fisher reported strong quarterly results …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Thermo Fisher Scientific Inc. $TMO Shares Sold by Wedge Capital Management L L P NC

Wedge Capital Management L L P NC significantly reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 93.3% in the second quarter, selling over 11,000 shares. Despite this, other institutional investors either increased or initiated stakes in the company, with institutional ownership remaining …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Security National Bank Boosts Stock Position in Thermo Fisher Scientific Inc. $TMO

Security National Bank increased its stake in Thermo Fisher Scientific Inc. (TMO) by 18.5% in the second quarter, bringing its total holdings to 14,095 shares valued at approximately $7.1 million. The article also notes that institutional investors own 89.23% of TMO, and analysts generally …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cannon Advisors Inc. Acquires New Shares in Thermo Fisher Scientific Inc. $TMO

Cannon Advisors Inc. recently purchased 3,971 shares of Thermo Fisher Scientific Inc. (NYSE:TMO) valued at approximately $2.12 million, making it their 17th biggest position. This acquisition comes as other hedge funds have also adjusted their holdings in TMO, while company insiders have sold a …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Brown Shipley& Co Ltd Acquires New Shares in Thermo Fisher Scientific Inc. $TMO

Brown Shipley & Co Ltd has acquired 10,509 shares of Thermo Fisher Scientific Inc. (NYSE:TMO) valued at approximately $5.27 million, making it their 11th largest holding. Thermo Fisher Scientific recently reported strong quarterly earnings, exceeding analyst estimates with an EPS of $6.03 and revenue …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Thermo Fisher Scientific and KYAN Technologies Sign MoU to Advance Functional Precision Oncology for Solid Tumours

Thermo Fisher Scientific and KYAN Technologies have signed an MoU to advance functional precision oncology for solid tumours. The collaboration will use patient-derived tumoroid models, functional drug-response screening, and genomic analysis to gather patient-relevant data across various cancers, aiming to improve therapeutic decision-making. They …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Astorg Cultures a New Diagnostics Company From Thermo Fisher

Astorg Partners has acquired Thermo Fisher Scientific's global microbiology business for $1.075 billion, creating an independent diagnostics company focused on microbial testing. The newly independent entity, which will operate under a new brand and CEO Dirk Bontridder, manufactures consumables and instruments for identifying and …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fund Update: 3,029,037 THERMO FISHER SCIENTIFIC (TMO) shares added to DODGE & COX portfolio

DODGE & COX has significantly increased its holdings in THERMO FISHER SCIENTIFIC (TMO) by adding 3,029,037 shares, as revealed in a recent SEC 13F filing for the Q2 2026 report period. This move comes amidst varied institutional investor activity, with some firms adding and …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Michael Shafer Sells 25,500 Shares of Thermo Fisher Scientific (NYSE:TMO) Stock

Michael Shafer, EVP of Thermo Fisher Scientific (NYSE:TMO), sold 25,500 shares of the company's stock for $15.3 million, reducing his direct holdings by 54.85%. This sale occurred via a pre-arranged Rule 10b5-1 trading plan. The transaction follows the company's stronger-than-expected quarterly results and a …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market

Thermo Fisher Scientific Inc. (TMO) saw its stock price fall by 1.18% on Thursday, closing at $595.89. This performance lagged behind the broader market, as the S&P 500 Index and the Dow Jones Industrial Average both posted gains. This marks the second consecutive day …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Thermo Fisher Scientific (TMO) EVP exercises options, then sells 25,500 shares

Michael D. Shafer, Executive Vice President at Thermo Fisher Scientific (TMO), exercised options for 25,500 shares of common stock at strike prices of $309.63 and $418.32 per share on August 11, 2026. Following the exercise, he sold all 25,500 shares at $600.00 per share, …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Axinn Advises Thermo Fisher Scientific On Completed $1.075 Billion Sale Of Microbiology Business To Astorg

Axinn advised Thermo Fisher Scientific Inc. (NYSE: TMO) on the completed sale of its microbiology business to Astorg, a private equity firm, for approximately $1.075 billion. The microbiology business specializes in antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical, and food safety …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Thermo Fisher closes $1.1B sale of microbiology unit to PE firm

Thermo Fisher Scientific has completed the sale of its microbiology unit to European private equity firm Astorg for $1.1 billion. The newly independent company will specialize in microbiology diagnostics, employing approximately 2,400 people across 13 global sites, and will be led by former PerkinElmer …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Luxembourg: Dirk Bontridder appointed CEO of Astorg’s microbiology diagnostics business following completion of acquisition from Thermo Fisher Scientific

Dirk Bontridder has been appointed CEO of the newly independent microbiology diagnostics platform formed after Astorg completed its acquisition of Thermo Fisher Scientific's global microbiology business. Bontridder brings over 25 years of international leadership experience from the life sciences, diagnostics, and industrial technology sectors, …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Y Intercept Hong Kong Ltd Cuts Stock Position in Thermo Fisher Scientific Inc. $TMO

Y Intercept Hong Kong Ltd significantly reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 84.1% in the second quarter, selling 14,076 shares and retaining 2,669 shares valued at $1.34 million. Despite this, Thermo Fisher Scientific reported strong quarterly earnings, beating analyst estimates …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fund Update: 22,749 THERMO FISHER SCIENTIFIC (TMO) shares added to Magellan Asset Management Ltd portfolio

Magellan Asset Management Ltd has increased its stake in Thermo Fisher Scientific (TMO) by adding 22,749 shares to its portfolio, as per a recent SEC 13F filing. The article also details significant institutional investor activity, insider trading, government contracts, congressional stock trading, and analyst …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sheets Smith Wealth Management Raises Holdings in Thermo Fisher Scientific Inc. $TMO

Sheets Smith Wealth Management significantly increased its stake in Thermo Fisher Scientific Inc. by 47.3% in the second quarter, bringing its total holdings to 5,200 shares valued at $2.61 million. This comes as Thermo Fisher Scientific reported strong quarterly earnings, beating analyst estimates with …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Thermo Fisher, Michael J. Fox Foundation Expand Parkinson’s Proteomics Resource with 5,500 Samples

Thermo Fisher Scientific and The Michael J. Fox Foundation have expanded the Parkinson’s Precision Medicine Initiative (PPMI) proteomic data resource by analyzing approximately 5,500 research samples using Olink Explore HT technology. This large-scale, open-access dataset is now available in PPMI’s repository to the global …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Thermo Fisher Completes $1.075B Sale of Microbiology Business to Astorg

Thermo Fisher Scientific has finalized the sale of its microbiology business to Astorg for approximately $1.075 billion, which includes cash and a $50 million seller note. This divestiture separates a $645 million-revenue operation from Thermo Fisher's Specialty Diagnostics segment, allowing Astorg to gain control …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg

WALTHAM, Mass., August 12, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, forconsideration of approximately $1.075 billion, consisting of …

TMO main company TMO main company TMOS34 main company TMO main company TN8 main company
Sharemaestro market context Trend signal active 52 weeks +39.2% · Next-week setup positive 55.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Can A New Vitiligo Registry Move The Needle For Thermo Fisher (TMO)?

Thermo Fisher Scientific (NYSE:TMO) mostly sells the instruments and supplies that let other companies do science, not the treatments themselves. So when the company said on July 29 that it had launched the PPD CorEvitas Vitiligo Registry on July 14, to track how patients …

TMO main company TMO main company TMOS34 main company TMO main company TMOF main company TN8 main company
Sharemaestro market context Trend signal active 52 weeks +39.2% · Next-week setup positive 55.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

$1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today

Thermo Fisher Scientific (NYSE: TMO) has significantly outperformed the market over the last decade, with an annualized return of 14.61%. An investment of $1000 in TMO stock 10 years ago would now be valued at $3,885.72. This demonstrates the substantial impact of compounded returns …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Thermo Fisher Says India Is One Of Its Fastest-Growing Markets

Thermo Fisher Scientific expects India to remain one of its fastest-growing markets, driven by increasing demands in biopharma, clean energy, and semiconductors, projecting double-digit growth. The company anticipates a 15-20% increase in its Indian customer base over the next five years and plans to …

TMO main company
Sharemaestro market context Trend signal started 52 weeks +18.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Thermo Fisher Scientific Collaborates with The Michael J. Fox Foundation to Advance Proteomics-Enabled Parkinson’s Precision Medicine

Thermo Fisher Scientific and The Michael J. Fox Foundation (MJFF) have completed a large-scale proteomic analysis of approximately 5,500 research samples from MJFF's Parkinson’s Precision Medicine Initiative (PPMI) study. This collaboration utilizes Olink technology to expand the PPMI proteomic data resource, making the data …

TMO main company TMO main company TMOS34 main company TMO main company TMOF main company TN8 main company
Sharemaestro market context Trend signal active 52 weeks +39.2% · Next-week setup positive 55.1% TMO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context